This handout is for acute gout flare (primary-care / ed — acute monoarthritis). Your care team identified this based on: acute hot, swollen, exquisitely painful single joint (acute monoarthritis) (acr 2020 fitzgerald pmid 32391934; margaretten jama 2007 pmid 17405973).
Other reasons your team may use this plan: classic podagra — acute 1st mtp flare (acr 2020 fitzgerald pmid 32391934); acute monoarthritis with fever / systemic illness — septic-arthritis cannot-miss (margaretten jama 2007 pmid 17405973); recurrent self-limited podagra episodes resolving in 7-14 d (acp 2017 qaseem pmid 27802508).
Take these medications exactly as prescribed. Do not stop or change a dose without talking to your provider.
| Medication | Starting dose | How | When | What it does |
|---|---|---|---|---|
| colchicine | 1.2 mg PO ×1, then 0.6 mg 1 h later (1.8 mg over 1 h), then 0.6 mg q12h-daily until resolution | PO | AGREE low-dose then q12h-daily | AGREE (Terkeltaub Arthritis Rheum 2010 PMID 20131255): low-dose 37.8% vs placebo 15.5% responders at 24 h (P=0.005); low-dose AE profile = placebo (OR 1.5, 95% CI 0.7-3.2), 0% severe diarrhoea/vomiting vs high-dose diarrhoea OR 21.3. ACR 2020 strong; low-dose strongly preferred (PMID 32391934) |
| naproxen | 500 mg PO BID × 5-7 d | PO | BID | ACR 2020 equal first-line; ACP 2017 strong/high-quality. Alternative indomethacin 50 mg PO TID (PMID 32391934; PMID 27802508) |
| indomethacin | 50 mg PO TID × 5-7 d | PO | TID | ACR 2020 equal first-line NSAID alternative for acute flare abort (PMID 32391934) |
| prednisone | 40 mg PO daily × 5 d (or 0.5 mg/kg/d taper over 10-14 d) | PO | daily | ACR 2020 equal first-line; preferred when CKD/NSAID/colchicine-restricted; ACP 2017 strong. Counsel glycaemic monitoring in diabetes (PMID 32391934; PMID 27802508) |
| methylprednisolone | IM 40-80 mg single dose; or IV 40-125 mg if NPO/severe | IM/IV | single | ACR 2020 — parenteral steroid when oral route unavailable or severe flare (PMID 32391934; EULAR 2016 PMID 27457514) |
| triamcinolone (intra-articular) | Intra-articular 20-40 mg (large joint) / 10 mg (small joint), single | intra-articular | single | ACR 2020 — IA steroid equal/superior for accessible monoarticular flare; ONLY after septic arthritis excluded by synovial analysis (never inject an infected joint) (PMID 32391934; EULAR 2016 PMID 27457514) |
| anakinra | 100 mg SC daily × 3-5 d | SC | daily | EULAR 2016 — IL-1 blocker when colchicine + NSAID + corticosteroids all contraindicated (PMID 27457514); ACR 2020 conditional off-label rescue (PMID 32391934) |
Plan: Acute gout flare abort (≤24 h onset) — comorbidity-gated; chronic ULT routed to msk.gout-chronic.core.v1 (ACR 2020 FitzGerald; EULAR 2016 Richette; AGREE Terkeltaub)
Use these zones to know what to do based on how you feel.
Call 911 or go to the nearest emergency room right away if you have:
Route to msk.gout-chronic.core.v1 for the longitudinal ULT shared decision (≥2 flares/yr, tophus, CKD≥3, urolithiasis, or already on ULT). Counsel: this acute engine ABORTS and REFERS — it does not manage urate. Return precautions: fever + hot joint, rapid worsening, no improvement in 48 h (ACP 2017 Qaseem PMID 27802508; ACR 2020 PMID 32391934)
Guideline: 2020 ACR Guideline for the Management of Gout (FitzGerald et al, Arthritis Care Res 2020) + 2016 EULAR updated recommendations (Richette et al) + ACP 2017 (Qaseem et al); septic-arthritis cannot-miss anchored to Margaretten JAMA Rational Clinical Examination 2007